The scrapie isoform of the prion protein PrPSc compared to the cellular isoform PrPC

Prions in Humans and Animals

Volumn , Issue , 2006, Pages 104-118

  Riesner, Detlev ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881705219     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110200171     Document Type: Chapter

References (59)

1. Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46:417-428.
2. Bendheim PE. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 1992; 42:149-156.
3. Oesch B, Westaway D, Walchli M, et al. (1985) A cellular gene encodes scrapie PrP(27-30) protein. Cell 40:735-746.
4. Bosque PJ, Ryon C, Telling G, et al. Prions in skeletal muscle. Proc Natl Acad Sci USA 2002; 99:3812-3817.
5. Bons N, Mestre-Frances N, Guiraud I, et al. Prion immunoreactivity in brain, tonsil, gastrointestinal epithelial cells, and blood and lymph vessels in lumerian zoo primates with spongiform encephalopathy. CR Acad Sci III 1979; 320:971-979.
6. Pattison IH, Hoare MN, Jebbett JN, et al. Spread of scrapie to sheep and goats by oral dosing with foetal membranes from scrapie-affected sheep. Vet Rec 1972; 90:465-468.
7. Pattison IH, Hoare MN, Jebbett JN, et al. Further observations on the production of scrapie in sheep by oral dosing with foetal membranes from scrapie-affected sheep. Br Vet J 1974; 130:65-67.
8. Sc accumulation in muscles of hamsters orally infected with scrapie. EMBO reports 2003; 4:530-533.
9. Sc accumulation in myocytes from sheep incubating natural scrapie. Nat Med 2004; 10:591-593.
10. Stahl N, Baldwin MA, Teplow DB, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993; 32:1991-2002.
11. Safar JG, Kellings K, Serban H, et al. Search for a prion-specific nucleic acid. J Virol 2005; 79:10796-10806.
12. Prusiner SB, McKinley MP, Bowman KA, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35:349-358.
13. Merz PA, Somerville RA, Wisniewski HM, et al. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 1981; 54:63-74.
14. McKinley MP, Meyer RK, Kenaga L, et al Scrapie prion rod formation tn-vitro requires both detergent extraction and limited proteolysis. J Virol 1991; 65:1340-1351.
15. Fischer M, Rulicke T, Raeber A, et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knock-out mice to scrapie. EMBO J 1996; 15:1255-1264.
16. Legname G, Baskakov IV, Nguyen HOB, et al. Synthetic mammalian prions. Science 2004: 305:673-676.
17. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob Disease. Ann Neurol 1996; 39:767-778.
18. Telling GC, Parchi P, DeArmond SJ, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079-2082.
19. Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of'new variant' CJD. Nature 1996; 383:685-690.
20. Scmolecules with different conformations. Nat Med 1998; 4:1157-1165.
21. Krishman R and Lindquist S. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005; 435:765-772.
22. Klein TR, Kirsch D, Kaufmann R, et al. Prion rods contain small amounts of two host sphin-golipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem 1998: 379:655-666.
23. McKinley MP, Braunfeld MB, Bellinger CG, et al. Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J Infect Dis 1986; 154:110-120.
24. Appel TR, Dumpitak Ch, Mathiesen U, et al. Prion rods contain an inert polysaccharide scaffold. Biol Chem 1999; 380:1295-1306.
25. Dumpitak C, Beekes M, Weinmann N, et al. The polysacchride scaffold of PrP27-30 is a common compound of natural prions and consists of α-linked polyglucose. Biol Chem 2005; 386:1149-1155.
26. Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-474.
27. Prusiner SB, Groth D, Serban A, et al. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci USA 1993; 90:2793-2797.
28. Riesner D, Kellings K, Post K, et al. Disruption of prion rods generates spherical particles composed of four to six PrP27-30 molecules that have a high α-helical content and are non-infectious. J Virol 1996; 70:1714-1722.
29. Pan KM, Baldwin M, Nguyen J et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion protein. Proc Natl Acad Sci USA 1993; 90:10962-10966.
30. Safar J, Roller PP, Gajdusek DC, et al. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 1993; 268:20276-20284.
31. Wille H, Michelitsch MD, Guenebaut V, et al. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 2002; 99:3563-3568.
32. Govaerts C, Wille H, Prusiner SB, et al. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci USA 2004: 101:8342-8347.
33. Nelson R, Sawaya MR, Balbirnie M, et al. Structure of the cross- spine of amyloid-like fibrils. Nature 2005; 435:773-778.
34. Ritter C, Maddelein ML, Siemer AB, et al. Correlation of structural elements and infectivity of the HET-s prion. Nature 2005; 435:844-848.
35. Baskakov IV, Legname G, Prusiner SB, et al. Folding of prion protein to its native c-helical conformation is under kinetic control. J Biol Chem 2001; 276:19687-19690.
36. Swietnicki W, Morillas M, Chen SG, et al. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 2000; 39:424-431.
37. Jackson GS, Hosszu LLP, Power A, et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 1999; 283:1935-1937.
38. Welker E, Raymond LD, Scheraga HA, et al. Intramolecular versus intermolecular disulfide bonds in prion proteins. J Biol Chem 2002: 277:33477-33481.
39. Jansen K, Schafer O, Birkmann E, et al. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. J Biol Chem 2001; 382:683-691.
40. Leffers KW, Schell J, Jansen K, et al. The structural transition of PrP into its pathogenic conformation is induced by unmasking hydropholic sites. J Mol Biol 2004; 344:839-853.
41. Xiong LW, Raymond LD, Hayes S, et al. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. J Neurochem 2001; 79:669-678.
42. DebBurman SK, Raymond GJ, Caughey B, et al. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997; 94:3938-13943.
43. Raymond G, Hope J, Kocisko DA, et al. Molecular assessment of the transmissibilities of BSE and Scrapie to humans. Nature 1997; 388:285-288.
44. Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999; 80:11-14.
45. Sc. J Mol Biol 2004; 346:645-659.
46. Leffers KW, Wille H, Stohr J, et al. Assembly of natural and recombinant prion protein into fibrils. J Biol Chem. 2005; 386:569-580.
47. Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:1515-1522.
48. Come JH, Fraser PE, Lansbury Jr, PT. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993; 90:5959-5963.
49. Eigen M. Prionics or the kinetic basis of prion diseases. Biophys Chem 1996; 63:A1-18.
50. Telling GC, Scott M, Mastianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995: 83:79-90.
51. Caughey B, Kocisko DA, Raymond GJ, et al. Aggregates of scrapie-associated prion protein induce the cell free conversion of protease-sen-sitive prion protein to the protease-resistant stage. Chem Biol 1995; 2:807-818.
52. Cc) not observed recombinant PrP. J Biol Chem 2000; 275:38081-38087.
53. Kaneko K, Vey M, Scott M, et al. COOH-ter-minal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci USA 1997; 94:2333-2338.
54. Taraboulos A, Scott M, Semenov A, et al. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121-132.
55. C with raft-like lipid membranes. Biol Chem, in press.
56. Post K, Pitschke M, Schafer O, et al. Rapid acquisition of -sheet structure in the prion protein prior to multimer formation. Biol Chem 1998; 379:1307-1317.
57. Sc In: Weissmann C, editor. Prions for physicians. Br Med Bull 2003; 66:21-33.
58. Cohen FE, Pan KM, Huang Z, et al. Structural clues to prion replication. Science 1994; 264:530-531
59. Caughey BW, Dong A, Bhat K. S, et al. Secondary structure analysis of the scrapie-associted protein PrP (27-30) in water by infrared spectroscopy. Biochemistry 1991; 30:7672-7680.